{
    "clinical_study": {
        "@rank": "161379", 
        "acronym": "3 4-DAP", 
        "brief_summary": {
            "textblock": "To learn more about the effect of 3, 4-Diaminopyridine (3,4-DAP) on patient diagnosed with\n      Lambert-Eaton myasthenic syndrome (LEMS)."
        }, 
        "brief_title": "Use of 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Syndrome", 
        "completion_date": {
            "#text": "March 2050", 
            "@type": "Anticipated"
        }, 
        "condition": "Lambert Eaton Myasthenic Syndrome", 
        "condition_browse": {
            "mesh_term": "Lambert-Eaton Myasthenic Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Be 18 years or older, diagnosed with LEMS.\n\n          -  If female, have a negative pregnancy test and, if premenopausal, be willing to\n             practice an effective form of birth control during the study.\n\n          -  Tested and found by ECG not to have a prolonged QT syndrome.\n\n          -  Agree to have a second ECG at the time of peak drug effect.\n\n          -  Has understood and signed the Informed Consent\n\n        Exclusion Criteria:\n\n          -  Is known to have a sensitivity to 3, 4-DAP.\n\n          -  Has a history of past or current seizures, cardiac arrhythmia, hepatic, renal or\n             hematologic disease or of severe asthma.\n\n          -  Is believed by the investigator to be unable to comply with the protocol.\n\n          -  Is unable to give informed consent.\n\n          -  Is pregnant."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "March 22, 2013", 
        "id_info": {
            "nct_id": "NCT01825395", 
            "org_study_id": "04-0567"
        }, 
        "intervention": {
            "arm_group_label": "3, 4-Diaminopyridine", 
            "intervention_name": "3, 4-Diaminopyridine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "3,4-diaminopyridine", 
                "4-Aminopyridine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "August 22, 2013", 
        "location": {
            "contact": {
                "last_name": "Janet Jones", 
                "phone": "303-724-2188"
            }, 
            "facility": {
                "address": {
                    "city": "Aurora", 
                    "country": "United States", 
                    "state": "Colorado", 
                    "zip": "80045"
                }, 
                "name": "University of Colorado"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Use of 3,4-Diaminopyridine(3 4-DAP)in the Treatment of Lambert-Eaton Syndrome (LEMS)", 
        "overall_contact": {
            "last_name": "Kathy Ales", 
            "phone": "6099217447"
        }, 
        "overall_official": {
            "affiliation": "University of Colorado, Denver", 
            "last_name": "Steven P Ringel, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Available", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2050", 
            "@type": "Anticipated"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01825395"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Colorado, Denver", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Colorado, Denver", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2004", 
        "study_design": "N/A", 
        "study_type": "Expanded Access", 
        "verification_date": "August 2013"
    }
}